-

$1.95 Bn Medical Overmolding Market Trends, Opportunities and Forecast to 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Medical Overmolding Market: Market Size, Trends, Opportunities and Forecast by Application, End-User Type, Overmold Material Type, Region, By Country: 2020-2030" report has been added to ResearchAndMarkets.com's offering.

Global Medical Overmolding Market was valued at USD 1.95 billion and is expected to grow at a CAGR of 4.3% during 2025-2030.

The Medical Overmolding Market is experiencing robust growth, driven by the increasing demand for enhanced medical devices that offer better performance, comfort, and durability. Overmolding is a manufacturing process where a material (typically a soft polymer) is molded over another material (usually a rigid substrate) to create a composite medical device. This technique is widely used in the production of medical instruments, surgical tools, catheters, and wearable devices, where ergonomics and patient comfort are critical.

One of the key drivers of the medical overmolding market is the growing demand for minimally invasive devices that require precise, biocompatible, and comfortable materials. Overmolding provides a smooth, ergonomic surface that reduces patient discomfort and enhances the usability of medical devices. The rise in chronic diseases and the aging population have led to an increased need for medical devices that can be used for long-term care, such as catheters, which benefit from overmolding to provide soft, flexible surfaces that minimize irritation.

Technological advancements in materials science, such as the development of biocompatible polymers, have further propelled the adoption of overmolding in medical device manufacturing. These materials are non-reactive, sterilizable, and suitable for contact with human tissue, making them ideal for medical applications. Additionally, overmolding enables manufacturers to create devices with integrated components, reducing assembly time and cost, and improving the overall durability of the device.

Geographical Insights

The Americas dominate the Medical Overmolding Market, driven by the region's advanced medical device manufacturing capabilities and high healthcare expenditure. The U.S., in particular, is a key market, with leading medical device manufacturers adopting overmolding techniques to enhance product performance. The Asia-Pacific region is also witnessing growth, fueled by rising healthcare infrastructure investments and increasing demand for advanced medical devices.

Reasons to buy this report:

  • In-Depth Comparative Assessment of Top 20 Markets in the Medical Overmolding Market End-User Type: Comparative assessment of 20 leading countries highlighting the total addressable market, opportunities, lucrative segments and competitive positioning of leading companies.
  • Comprehensive Historical, Present, and Future Analytics of the Medical Overmolding Market: A deep dive in the historical (2020-2023), current (2024) and forecast (2025-2030) market analytics of Medical Overmolding Market.
  • Detailed Analysis of Medical Overmolding Market By Application, End-User Type, and Overmold Material Type Across 20 Countries
  • Beyond the Purchase: 90 Days of Support
  • Direct Access to Analysts: Have questions after reading the report? Our expert analysts are just a call or email away.
  • Customized Assistance: Whether you're integrating insights into your strategy or have questions about market dynamics, our team provides tailored support to meet your specific business needs.
  • Data Customization Requests: During the support period, you have the flexibility to request additional data cuts or deeper dives into specific areas of interest.
  • Gain insights specific to new entrants or new market areas to tap: The study provides detailed market entry strategies, including analysis of barriers to entry, pricing strategies, opportunities, trends, drivers, and challenges and product positioning using the Opportunity Portfolio Matrix (OPM)
  • Strategic Movements: Tracking Competitive Developments and Key Players in the Market: The report covers competitive strategies, mergers & acquisitions, new developments, future plans and market share analysis of ~15 top companies.

Key companies in the Global Medical Overmolding Market include:

  • TE Connectivity
  • Phillips-Medisize (a Molex company)
  • ProMed Molded Products, Inc.
  • Biomerics, LLC
  • Medbio, LLC
  • Trelleborg AB
  • Avient Corporation
  • Kaysun Corporation
  • Saint-Gobain
  • MGS Mfg. Group, Inc.

Market Segmentation

By Application:

  • Surgical Instruments
  • Tubing Parts
  • Medical Cable
  • Needle Components
  • Other Applications

By End-User Type:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers
  • Other End-User Types

By Overmold Material Type:

  • Silicon
  • Thermoplastic

By Geography:

  • Americas (The United States, Canada, Brazil, Mexico, Rest of Americas)
  • Europe (United Kingdom, Germany, France, Italy, Spain, Turkey, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, South Korea, India, Singapore, Indonesia, Rest of Asia Pacific)
  • Middle East and Africa (GCC, Israel, South Africa, Rest of Middle East and Africa)

For more information about this report visit https://www.researchandmarkets.com/r/z5ynoo

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Pharmaceutical Regulatory Affairs in Asia Training Course: Important Aspects of Gaining and Maintaining a Successful Marketing Authorisation (Mar 24th - Mar 26th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs in Asia Training Course (Mar 24th - Mar 26th, 2026)" training has been added to ResearchAndMarkets.com's offering. The pharmaceutical market in Asia is growing at a rapid pace and presents both opportunities and challenges to those wishing to work in the region. Rather than a single market, Asia is a collection of different markets, each with their own regulatory processes, although harmonisation exists within the ASEAN countries....

European Union Veterinary Pharmacovigilance Introductory Training Course: Practical Guidance and Basic Training for All Those Working in Drug Safety (Mar 9th - Mar 10th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to Veterinary Pharmacovigilance Training Course (Mar 9th - Mar 10th, 2026)" training has been added to ResearchAndMarkets.com's offering. This two-day event has been designed to provide an essential overview of veterinary pharmacovigilance and will offer practical guidance and basic training for all those working in drug safety in the EU. Our experienced trainer will clarify roles and responsibilities, explain commonly used terminology and take partici...

Pharma and Medical Device Clinical Quality Management Systems Training Course: EMA Guidance on Computerised Systems and ICH GCP R3 Data Governance (Mar 23rd - Mar 24th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Quality Management Systems Training Course (Mar 23rd - Mar 24th, 2026)" training has been added to ResearchAndMarkets.com's offering. This course will provide essential information and guidance to help you achieve regulatory compliance in this evolving area of clinical quality, including EMA guidance on computerised systems and ICH GCP R3 data governance. With increasing clinical quality standards required by inspectors, there is currently no harmonised re...
Back to Newsroom